Cash Flow Statement
Growth Metrics

Mimedx (MDXG) Gains from Investment Securities (2016 - 2026)

Mimedx's Gains from Investment Securities history spans 15 years, with the latest figure at $1.9 million for Q1 2026.

  • On a quarterly basis, Gains from Investment Securities fell 22.66% to $1.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $2.5 million, a 639.24% increase, with the full-year FY2025 number at $3.1 million, up 8057.89% from a year prior.
  • Gains from Investment Securities hit $1.9 million in Q1 2026 for Mimedx, down from $3.1 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for MDXG hit a ceiling of $3.1 million in Q4 2025 and a floor of -$2.5 million in Q3 2024.
  • Historically, Gains from Investment Securities has averaged $537785.7 across 5 years, with a median of $240500.0 in 2023.
  • Biggest five-year swings in Gains from Investment Securities: soared 16914.29% in 2022 and later plummeted 15618.75% in 2024.
  • Tracing MDXG's Gains from Investment Securities over 5 years: stood at $1.1 million in 2022, then crashed by 88.18% to $132000.0 in 2023, then crashed by 84.85% to $20000.0 in 2024, then skyrocketed by 15400.0% to $3.1 million in 2025, then plummeted by 38.68% to $1.9 million in 2026.
  • Business Quant data shows Gains from Investment Securities for MDXG at $1.9 million in Q1 2026, $3.1 million in Q4 2025, and -$2.5 million in Q2 2025.